Alpine Catapults 37% After Vertex Pledges $4.9 Billion To Buy It
Investor's Business DailyVertex Pharmaceuticals will pay $4.9 billion to acquire Alpine Immune Sciences. Alpine stock rocketed almost 21% on rumors of the deal.
The post Alpine Catapults 37% After Vertex Pledges $4.9 Billion To Buy It appeared first on Investor's Business…